Skip to main content

Advertisement

SpringerLink
Log in

Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop

  • Original Article
  • Published:
Tumor Biology

Abstract

Recent studies reported that long non-coding RNAs (lncRNAs) might play critical roles in regulating endocrine resistance of breast cancer. Urothelial carcinoma-associated 1 (UCA1) is an lncRNA with an oncogenic role in breast cancer. This study aimed to investigate whether UCA1 is involved in acquired tamoxifen resistance in estrogen receptor (ER)-positive cancer cells. Our findings reveal that tamoxifen induces UCA1 upregulation in ER-positive breast cancer cells in a HIF1α-dependent manner. UCA1 upregulation results in significantly enhanced tamoxifen resistance. The upregulated UCA1 sponges miR-18a, which is a negative regulator of HIF1α. Therefore, UCA1 upregulation is further enhanced through a miR-18a-HIF1α feedback loop. In addition, our data also showed that miR-18a is a modulator of tamoxifen sensitivity due to its regulative effect on cell cycle proteins. miR-18a inhibitor reduced the sensitivity of MCF-7 cells to tamoxifen, while miR-18a mimics sensitized BT474 cells to tamoxifen. Therefore, miR-18a downregulation also partly contributes to acquired tamoxifen resistance in the cancer cells. These findings provide some useful information for future clinical treatment of tamoxifen resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  2. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, Schiff R. Role of the estrogen receptor coactivator aib1 (src-3) and her-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst. 2003;95:353–61.

    Article  CAS  PubMed  Google Scholar 

  3. Gojis O, Rudraraju B, Gudi M, Hogben K, Sousha S, Coombes RC, Cleator S, Palmieri C. The role of src-3 in human breast cancer. Nature reviews Clinical oncology. 2010;7:83–9.

    Article  CAS  PubMed  Google Scholar 

  4. Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.

    Article  Google Scholar 

  5. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhang F, Zhang L, Zhang C. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies. Tumour Biol J Int Soc Oncodev Biol Med. 2016;37:163–75.

  7. Zhu S, Mao J, Shao Y, Chen F, Zhu X, Xu D, Zhang X, Guo J. Reduced expression of the long non-coding RNA ai364715 in gastric cancer and its clinical significance. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:8041–5.

    Article  CAS  Google Scholar 

  8. Zhang HM, Yang FQ, Chen SJ, Che J, Zheng JH. Upregulation of long non-coding RNA malat1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:2947–55.

    Article  CAS  Google Scholar 

  9. Hayes EL, Lewis-Wambi JS. Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA. Breast cancer research: BCR. 2015;17:40.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Godinho MF, Sieuwerts AM, Look MP, Meijer D, Foekens JA, Dorssers LC, van Agthoven T. Relevance of bcar4 in tamoxifen resistance and tumour aggressiveness of human breast cancer. Br J Cancer. 2010;103:1284–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Meijer D, van Agthoven T, Bosma PT, Nooter K, Dorssers LC. Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells. Molecular cancer research: MCR. 2006;4:379–86.

    Article  CAS  PubMed  Google Scholar 

  12. Jonsson P, Coarfa C, Mesmar F, Raz T, Rajapakshe K, Thompson JF, Gunaratne PH, Williams C. Single-molecule sequencing reveals estrogen-regulated clinically relevant lncrnas in breast cancer. Mol Endocrinol. 2015;29:1634–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Xue X, Yang YA, Zhang A, Fong KW, Kim J, Song B, et al. Lncrna hotair enhances er signaling and confers tamoxifen resistance in breast cancer. Oncogene. 2016;35:2746–55.

  14. Wang XS, Zhang Z, Wang HC, Cai JL, QW X, Li MQ, Chen YC, Qian XP, TJ L, LZ Y, Zhang Y, Xin DQ, Na YQ, Chen WF. Rapid identification of uca1 as a very sensitive and specific unique marker for human bladder carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2006;12:4851–8.

    Article  CAS  Google Scholar 

  15. Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo YY. Long non-coding RNA uca1 promotes breast tumor growth by suppression of p27 (kip1). Cell Death Dis. 2014;5:e1008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Tuo YL, Li XM, Luo J. Long noncoding RNA uca1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive mir-143. European review for medical and pharmacological sciences. 2015;19:3403–11.

    PubMed  Google Scholar 

  17. Jiang M, Huang O, Xie Z, Wu S, Zhang X, Shen A, Liu H, Chen X, Wu J, Lou Y, Mao Y, Sun K, Hu S, Geng M, Shen K. A novel long non-coding RNA-ara: adriamycin resistance-associated. Biochem Pharmacol. 2014;87:254–83.

    Article  CAS  PubMed  Google Scholar 

  18. Xue M, Li X, Wu W, Zhang S, Wu S, Li Z, Chen W. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by ccaat/enhancer binding protein alpha contributes to bladder cancer cell growth and reduced apoptosis. Oncol Rep. 2014;31:1993–2000.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. Hif-1alpha induces cell cycle arrest by functionally counteracting myc. EMBO J. 2004;23:1949–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Chen S, Shao C, Xu M, Ji J, Xie Y, Lei Y, Wang X. Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA uca1. International journal of clinical and experimental pathology. 2015;8:9052–61.

    PubMed  PubMed Central  Google Scholar 

  21. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y. Long non-coding RNA uca1 increases chemoresistance of bladder cancer cells by regulating wnt signaling. The FEBS journal. 2014;281:1750–8.

    Article  CAS  PubMed  Google Scholar 

  22. Wang F, Zhou J, Xie X, Hu J, Chen L, Hu Q, Guo H, Yu C. Involvement of srpk1 in cisplatin resistance related to long non-coding RNA uca1 in human ovarian cancer cells. Neoplasma. 2015;62:432–8.

    Article  CAS  PubMed  Google Scholar 

  23. Xue M, Li X, Li Z, Chen W. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1alpha-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:6901–12.

    Article  CAS  Google Scholar 

  24. Liu S, Song L, Zeng S, Zhang L. Malat1-mir-124-rbg2 axis is involved in growth and invasion of hr-hpv-positive cervical cancer cells. Tumour Biol J Int Soc Oncodev Biol Med. 2016;37:633–40.

  25. Xue M, Pang H, Li X, Li H, Pan J, Chen W. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-mir-145-zeb1/2-fscn1 pathway. Cancer Sci. 2016;107:18–27.

  26. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human risc couples microrna biogenesis and posttranscriptional gene silencing. Cell. 2005;123:631–40.

    Article  CAS  PubMed  Google Scholar 

  27. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, Kong R, Xia R, Lu KH, Li JH, De W, Wang KM, Wang ZX. Lnc rna hotair functions as a competing endogenous RNA to regulate her2 expression by sponging mir-331-3p in gastric cancer. Mol Cancer. 2014;13:92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y, Guo J. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Scientific reports. 2014;4:6088.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Wu F, Huang W, Wang X. MicroRNA-18a regulates gastric carcinoma cell apoptosis and invasion by suppressing hypoxia-inducible factor-1alpha expression. Experimental and therapeutic medicine. 2015;10:717–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Song L, Lin C, Wu Z, Gong H, Zeng Y, Wu J, Li M, Li J. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (atm) kinase. PLoS One. 2011;6:e25454.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Humphreys KJ, McKinnon RA, Michael MZ. miR-18a inhibits cdc42 and plays a tumour suppressor role in colorectal cancer cells. PLoS One. 2014;9:e112288.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Qian Y, Shi D, Qiu J, Zhu F, Qian J, He S, Shu Y, Yin Y, Chen X. Obrb downregulation increases breast cancer cell sensitivity to tamoxifen. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:6813–21.

    Article  CAS  Google Scholar 

  34. Cheng N, Cai W, Ren S, Li X, Wang Q, Pan H, et al. Long non-coding RNA uca1 induces non-t790 m acquired resistance to egfr-tkis by activating the akt/mtor pathway in egfr-mutant non-small cell lung cancer. Oncotarget. 2015;6:23582–93.

  35. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microrna sponges. Nature. 2013;495:384–8.

    Article  CAS  PubMed  Google Scholar 

  36. Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao X, Chen WS, Li B. LncRNA-uca1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett. 2016;371:99–106.

    Article  CAS  PubMed  Google Scholar 

  37. Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK. Upregulated lncRNA-uca1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of fgfr1/erk signaling pathway. Oncotarget. 2015;6:7899–917.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Krutilina R, Sun W, Sethuraman A, Brown M, Seagroves TN, Pfeffer LM, Ignatova T, Fan M. MicroRNA-18a inhibits hypoxia-inducible factor 1alpha activity and lung metastasis in basal breast cancers. Breast cancer research: BCR. 2014;16:R78.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by Beijing Natural Science Foundation (7142055.)

Author information

Authors and Affiliations

  1. Department of Breast Surgery, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100006, China

    Xiunan Li, Aihui Liu & Xin Tang

  2. Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, 17#, Qihelou Street, Dongcheng District, Beijing, 100006, China

    Yumei Wu

Authors
  1. Xiunan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yumei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aihui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yumei Wu.

Ethics declarations

Conflicts of interest

None.

Electronic supplementary material

ESM 1

(DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Wu, Y., Liu, A. et al. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop. Tumor Biol. 37, 14733–14743 (2016). https://doi.org/10.1007/s13277-016-5348-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-5348-8

Keywords

Search

Navigation